SB

Samsara BioCapital Portfolio holdings

AUM $489M
This Quarter Return
+6.94%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$497M
AUM Growth
+$497M
Cap. Flow
+$95.6M
Cap. Flow %
19.24%
Top 10 Hldgs %
67.16%
Holding
50
New
7
Increased
5
Reduced
6
Closed
8

Top Buys

1
TIL icon
Instil Bio
TIL
$39M
2
BOLT icon
Bolt Biotherapeutics
BOLT
$24.3M
3
TERN icon
Terns Pharmaceuticals
TERN
$10.9M
4
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
$9.39M
5
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$7.69M

Top Sells

1
ACRS icon
Aclaris Therapeutics
ACRS
$8.57M
2
SWTX
SpringWorks Therapeutics
SWTX
$6.82M
3
EQ icon
Equillium
EQ
$2.22M
4
BCEL
Atreca, Inc. Class A Common Stock
BCEL
$1.2M
5
ATXS icon
Astria Therapeutics
ATXS
$434K

Sector Composition

1 Healthcare 97.77%
2 Financials 1.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EYPT icon
26
EyePoint Pharmaceuticals
EYPT
$797M
$4.57M 0.84%
+450,000
New +$4.57M
RYTM icon
27
Rhythm Pharmaceuticals
RYTM
$6.85B
$4.28M 0.79%
201,046
– –
ALPN
28
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$4.23M 0.78%
399,190
– –
KALA icon
29
KALA BIO
KALA
$78.8M
$4.05M 0.75%
601,162
– –
VTGN icon
30
VistaGen Therapeutics
VTGN
$102M
$3.9M 0.72%
1,831,490
+191,122
+12% +$407K
ALBO
31
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$3.53M 0.65%
100,000
– –
IMCR icon
32
Immunocore
IMCR
$1.62B
$3.41M 0.63%
+80,000
New +$3.41M
BLSA
33
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$3.17M 0.58%
300,000
– –
CHFW.U
34
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$2.93M 0.54%
300,000
– –
RCKT icon
35
Rocket Pharmaceuticals
RCKT
$354M
$2.83M 0.52%
63,770
– –
ODT
36
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$2.4M 0.44%
700,421
-115,000
-14% -$393K
SNCE
37
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$2.03M 0.37%
200,000
– –
KLRS
38
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
$1.93M 0.36%
82,336
– –
BNTX icon
39
BioNTech
BNTX
$24B
$1.18M 0.22%
10,795
– –
NGM
40
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$530K 0.1%
18,225
– –
ATXS icon
41
Astria Therapeutics
ATXS
$349M
$434K 0.08%
150,000
-150,000
-50% -$434K
AMRN
42
Amarin Corp
AMRN
$311M
$155K 0.03%
25,000
– –
GERN icon
43
Geron
GERN
$893M
– –
-1,224,870
Closed -$1.95K
HOOK
44
DELISTED
HOOKIPA Pharma
HOOK
– –
-129,660
Closed -$1.44K
KALV icon
45
KalVista Pharmaceuticals
KALV
$678M
– –
-67,270
Closed -$1.28K
SPRY icon
46
ARS Pharmaceuticals
SPRY
$1.15B
– –
-25,000
Closed -$1.16K
KDMN
47
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-165,000
Closed -$685
PANA.U
48
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
– –
-400,000
Closed -$5.1K
COGT icon
49
Cogent Biosciences
COGT
$1.69B
– –
-588,961
Closed -$6.61K
FULC icon
50
Fulcrum Therapeutics
FULC
$351M
– –
-294,118
Closed -$3.44K
1
2